Clinical trial
Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious…
NCT00344942 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00344942 |
|---|---|
| Title | Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults |
| Official title | A Randomised, Double-blind, French Multi-centre Study, to Evaluate the Efficacy and Tolerance, in Comparison With Placebo, of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults |
| Acronym | RhiCNANI |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis |
| Intervention type | Drug |
| Interventions | triamcinolone acetonide, placebo |
| Enrollment | 77 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2007 |
| First posted | Jun 27, 2006 |
| Last update posted | Dec 7, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: